(Q51618281)

8 April 2018

title

Mexiletine has no effect on defibrillation energy requirements in dogs. (English)

1 reference

8 April 2018

author name string

Sato S

series ordinal

1

1 reference

8 April 2018

Tsuji MH

series ordinal

2

1 reference

8 April 2018

Naito H

series ordinal

3

1 reference

8 April 2018

publication date

1 December 1994

1 reference

8 April 2018

Pacing and Clinical Electrophysiology

published in

1 reference

8 April 2018

volume

17

1 reference

8 April 2018

issue

12 Pt 1

1 reference

8 April 2018

page(s)

2279-2284

1 reference

8 April 2018

Practical considerations in the treatment of ventricular arrhythmias with mexiletine

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Effects of chronic amiodarone therapy on defibrillation threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Effects of encainide and its metabolites on energy requirements for defibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

DL and D sotalol decrease defibrillation energy requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Implanted automatic defibrillators: effects of drugs and pacemakers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Potential Interactions Between Antiarrhythmic Medication And The Automatic Implantable Cardioverter Defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Effects of lidocaine and verapamil on defibrillation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Electrical threshold for defibrillation of canine ventricles following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

The clinical pharmacology of mexiletine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.1994.TB02376.X

10.1111/J.1540-8159.1994.TB02376.X

21 January 2018

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018